AcelRx Pharmaceuticals Inc (ACRX)

2.15
NASDAQ : Health Care
Prev Close 2.40
Day Low/High 2.15 / 2.50
52 Wk Low/High 1.95 / 4.08
Avg Volume 285.50K
Exchange NASDAQ
Shares Outstanding 45.38M
Market Cap 108.91M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Adding to AcelRx on Weakness

Shares have dropped to the level we mentioned Friday.

Initiating Position in Biotech; Update on ACRX

We're buying a small position in Inovio Pharmaceuticals and downgrading AcelRx.

Stocks Under $10 Weekly Summary

We scaled further into one position and added a Bullpen name as the market shrugged off geopolitical uncertainties.

Stocks Under $10 Weekly Summary

We exited 3 names last week as stocks continued their run.

Stocks Under $10 Weekly Summary

It was a busy week of moves in the portfolio as we head into the latter half of the second quarter.

Adding a Specialty Pharma Name

AcelRx Pharmaceuticals is another interesting, yet speculative, play.

AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer

- Howie Rosen to Continue on Board of Directors -

AcelRx Pharmaceuticals Reports On ARX-04 Market And Landscape Presented At Analyst & Investor Event

AcelRx Pharmaceuticals Reports On ARX-04 Market And Landscape Presented At Analyst & Investor Event

- Peak revenue opportunity for ARX-04 estimated to be $1.1 billion

AcelRx Pharmaceuticals To Host Analyst & Investor Event On December 1, 2016

AcelRx Pharmaceuticals To Host Analyst & Investor Event On December 1, 2016

- Expert panel to discuss market opportunity in emergency medicine for investigational agent ARX-04 (sufentanil sublingual tablet, 30 mcg) for the treatment of moderate-to-severe acute pain

ACRX: Insiders vs. Shorts

ACRX: Insiders vs. Shorts

The most recent short interest data was recently released for the 09/30/2016 settlement date, and AcelRx Pharmaceuticals Inc is one of the most shorted stocks of the Russell 3000, based on 8.72 "days to cover" versus the median component at 5.36. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.